Veracyte VCYT Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $66.35M+175% | $24.14M+132% | -$74.4M-104% | -$36.56M+51.6% | ||
| $21.42M-8.7% | $23.46M-13.7% | $27.19M+4.9% | $25.93M+32.3% | ||
| $43.6M+20.3% | $36.25M+9.4% | $33.14M+24.0% | $26.73M+18.7% | ||
| $136.31M+81.5% | $75.1M+69.8% | $44.22M+487% | $7.54M— | ||
| $9.68M-14.3% | $11.29M+13.3% | $9.96M+16.5% | $8.55M+59.0% | ||
| —— | -$56.28M— | —— | —— | ||
| —— | —— | $2.84M-20.5% | $3.57M-99.4% | ||
| $123.6M— | —— | $62.33M— | —— | ||
| $126.63M+98.5% | $63.81M+86.2% | $34.26M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Veracyte's cash flow data come from?
- Every line is extracted from Veracyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.